Monopar Therapeutics Inc (MNPR) is a biotechnology company listed on US.
Latest reported MNPR revenue for 2026-06-30 was $0. Net income was -$9.2M. MNPR currently screens at market cap $431.4M.
Use this MNPR page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the MNPR quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the MNPR SEC filings page. Lician reads the product cache first so this HTML stays unique to Monopar Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full MNPR income, balance, and cash tables.